Improving Alzheimer's disease phase II clinical trials-Reference-Cited by-同舟云学术

Improving Alzheimer's disease phase II clinical trials

Published:2012-11-19 Issue:1 Volume:9 Page:39-49
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Greenberg Barry D.¹,Carrillo Maria C.²,Ryan J. Michael³,Gold Michael⁴,Gallagher Kim⁵,Grundman Michael⁶,Berman Robert M.⁷,Ashwood Timothy⁸,Siemers Eric R.⁹

Affiliation:

1. Division of Neuroscience Drug Discovery and DevelopmentUniversity Health NetworkTorontoONCanada

2. Medical & Scientific Relations Alzheimer's AssociationChicagoILUSA

3. Pfizer Inc.CollegevillePAUSA

4. Allon TherapeuticsVancouverBCCanada

5. GE HealthcareWauwatosaWIUSA

6. Global R&D Partners, LLCSan DiegoCAUSA

7. Bristol Myers SquibbWallingfordCTUSA

8. AstraZenecaSödertäljeSweden

9. Eli Lilly and Company, Lilly Research LaboratoriesIndianapolisINUSA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2012.02.002

Reference77 articles.

1. Clinical forecasting in drug development

2. Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009

3. Can the pharmaceutical industry reduce attrition rates?

4. Physostigmine for Alzheimer's disease;Coelho F;Cochrane Database Syst Rev,2001

5. Tacrine: First Drug Approved for Alzheimer's Disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development;Neurology;2024-07-09

2. NORHA: A NORmal Hippocampal Asymmetry Deviation Index Based on One-Class Novelty Detection and 3D Shape Features;Brain Topography;2023-06-29

3. Alzheimer’s Disease Drug Development: A Research and Development Ecosystem;Alzheimer's Disease Drug Development;2022-03-31

4. Multimodal brain imaging effect of “Adjust Zang-fu and Arouse Spirit” electroacupuncture on diabetic cognitive impairment: study protocol of a randomized, sham-controlled pilot trial;Trials;2021-11-25

5. Association of peripheral blood DNA methylation level with Alzheimer’s disease progression;Clinical Epigenetics;2021-10-15